Dr. Giuseppe Condemi, MD, PhD

Dr. Condemi practices at Holy Name Medical Center in Teaneck, New Jersey, part of Holy Name Medical Center.

Dr. Condemi's NPI, 1083660781, was assigned on May 25, 2006. Dr. Condemi graduated from Ross University School of Medicine in 1998. Dr. Condemi holds New York license 221674.

Dr. Condemi's primary practice is Holy Name Medical Center, at 718 Teaneck Rd, Teaneck, NJ 07666 in Bergen County. The practice phone is (201) 833-3000.

Dr. Condemi's primary practice is Holy Name Medical Center in Teaneck, New Jersey, part of Holy Name Medical Center. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Condemi to 2 more group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Condemi practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Condemi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Condemi's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Condemi treats.

CMS data shows 19,988 Medicare services from Dr. Condemi across 50 procedure codes in 2024, for 370 Medicare patients. Medicare paid $127,378 for them. Every service was in an office.

CMS counts 370 Medicare patients who saw Dr. Condemi in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Condemi's median patient age at 53, with 69% women.

In 2024, Dr. Condemi wrote 224 Medicare Part D claims for 84 patients. 61% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $27,561 in total drug cost. In 2023, CMS named 999 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Condemi for performance year 2024, reported as part of a group. Dr. Condemi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Condemi to 1 clinical trial.

CMS Open Payments shows 303 general payments to Dr. Condemi from 65 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $576.

Dmand AI lists 4 awards for Dr. Condemi, most recently Inside Jersey Magazine Top Doctors in 2014.

Dr. Condemi graduated from Ross University School of Medicine in 1998. Dr. Condemi is a member of ASCO.

Dr. Condemi is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.